OQROSign up free
Insider trade

Aeon Biopharma (AEON): 10% owner bought ~$243K

LYNCH TIMOTHY P, 10% owner at Aeon Biopharma, bought ~$243K of Aeon Biopharma shares.

~$243K
Approx. value · 1.15M sh @ $0.2117
6.5M
Holds after · shares reported
Traded
Aug 19, 2026
Filed
Aug 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 13, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  2. Aug 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Aug 19, 2026 · this disclosureInsider · First insider buy since May 202510% owner purchased ~$243K of AEON shares in the open market

What came next

  1. Nov 2, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Nov 10, 20265% stakeDaewoong Co., Ltd. filed an activist stake (13D) of 30.6%
  3. Nov 13, 20265% stakeNantahala Capital Management, LLC reported a passive stake (13G) of 10.0%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aeon Biopharma

For Aeon Biopharma, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AEON page.

How this filing works

Explore the data

Other disclosures at Aeon Biopharma

Everything OQRO holds on this company is on its AEON page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data